CREX

Creative Realities, Inc.

48
Fundamentals43/ 100
Valuation50/ 100
Upside potential58/ 100
Risk potential28/ 100

CREX has lower modeled downside risk, despite its lower overall score.

INTC

Intel Corporation

65
Fundamentals73/ 100
Valuation50/ 100
Upside potential64/ 100
Risk potential42/ 100

INTC has the edge over CREX overall, supported by stronger fundamentals and stronger modeled upside.

CREX Fundamentals

MetricStatus
Strong
Weak
Weak
Stable

CREX's revenue is currently strong, and its balance sheet is stable, but its profitability and cash flow are weak.

INTC Fundamentals

MetricStatus
Healthy
Under pressure
Healthy
Healthy

INTC's revenue, cash flow and balance sheet are currently healthy, but its profitability is under pressure.

CREX PE Valuation

CREX has no meaningful PE right now: it lost money over the past year.

INTC PE Valuation

INTC has no meaningful PE right now: it lost money over the past year.

CREX Forward outlook

MetricOutlook
--
Losses shrinking
Strong growth
Strongly improving
Limited
High

Analysts expect CREX's losses to shrink, with revenue growing.

INTC Forward outlook

MetricOutlook
--
Strong growth
Growth
Strongly improving
Broad
Low

Analysts expect earnings and revenue growth for INTC, with profitability improving. However, they disagree widely on these estimates.

CREX Risk to reward

ScenarioChangePrice
Upside+39%$2.98
Downside-27%$1.56

Calculated from the latest close: $2.15 on Nov 12.

CREX trails INTC on modeled risk to reward, with less potential upside relative to its potential downside.

INTC Risk to reward

ScenarioChangePrice
Upside+76%$107.41
Downside-42%$35.74

Calculated from the latest close: $61.20 on Nov 12.

INTC has a better modeled risk to reward balance than CREX, with more potential upside relative to its potential downside.

CREX Earnings Per Share

Q4 2023: $-0.35Q1 2024: $-0.22Q2 2024: $-0.09Q3 2024: $0.14Q4 2024: $-0.34Q1 2025: $-0.01Q2 2025: $-0.12Q3 2025: $-0.88Q4 2025: $-0.81Q1 2026: $-1.87Q2 2026: $-2.11
Q4 2023: $-0.35Q1 2024: $-0.22Q2 2024: $-0.09Q3 2024: $0.14Q4 2024: $-0.34Q1 2025: $-0.01Q2 2025: $-0.12Q3 2025: $-0.88Q4 2025: $-0.81Q1 2026: $-1.87Q2 2026: $-2.11
QuarterTTM EPSYoY
Q2 2026-$2.11-$1.99
Q1 2026-$1.87-$1.86
Q4 2025-$0.81-$0.47
Q3 2025-$0.88-729%
Q2 2025-$0.12-$0.03
Q1 2025-$0.01+$0.21
Q4 2024-$0.34+$0.01
Q3 2022$0.15-55%

CREX is still losing money, but far less than before: $2.11 per share over the past year, against $5.16 at its worst in late 2020.

INTC Earnings Per Share

Q4 2023: $0.40Q1 2024: $0.97Q2 2024: $0.24Q3 2024: $-3.71Q4 2024: $-4.38Q1 2025: $-4.48Q2 2025: $-4.77Q3 2025: $0.01Q4 2025: $-0.06Q1 2026: $-0.60Q2 2026: $-2.09Q3 2026: $-2.39Forward: $1.41
Q4 2023: $0.40Q1 2024: $0.97Q2 2024: $0.24Q3 2024: $-3.71Q4 2024: $-4.38Q1 2025: $-4.48Q2 2025: $-4.77Q3 2025: $0.01Q4 2025: $-0.06Q1 2026: $-0.60Q2 2026: $-2.09Q3 2026: $-2.39Forward: $1.41
QuarterTTM EPSYoY
Forward$1.41—
Q3 2026-$2.39-24000%
Q2 2026-$2.09+$2.68
Q1 2026-$0.60+$3.88
Q4 2025-$0.06+$4.32
Q3 2025$0.01+$3.72
Q2 2025-$4.77-2088%
Q1 2025-$4.48-562%
Q4 2024-$4.38-1195%

INTC has the edge over CREX on earnings, with more consistent year-over-year improvement.

CREX Quarterly Revenue

Q3 2023: $12MQ4 2023: $14MQ1 2024: $12MQ2 2024: $13MQ3 2024: $14MQ4 2024: $11MQ1 2025: $10MQ2 2025: $13MQ3 2025: $11MQ4 2025: $24MQ1 2026: $16MQ2 2026: $22M
Q3 2023: $12MQ4 2023: $14MQ1 2024: $12MQ2 2024: $13MQ3 2024: $14MQ4 2024: $11MQ1 2025: $10MQ2 2025: $13MQ3 2025: $11MQ4 2025: $24MQ1 2026: $16MQ2 2026: $22M
QuarterRevenueYoY
Q2 2026$21.5M+65%
Q1 2026$16.3M+68%
Q4 2025$23.9M+117%
Q3 2025$10.5M-27%
Q2 2025$13M-0.6%
Q1 2025$9.7M-21%
Q4 2024$11M-24%
Q3 2024$14.4M+25%

CREX's revenue is recovering but still below its 2022 peak: $22M last quarter, up 65% from the same quarter a year ago.

INTC Quarterly Revenue

Q4 2023: $15.4BQ1 2024: $12.7BQ2 2024: $12.8BQ3 2024: $13.3BQ4 2024: $14.3BQ1 2025: $12.7BQ2 2025: $12.9BQ3 2025: $13.7BQ4 2025: $13.7BQ1 2026: $13.6BQ2 2026: $16.1BQ3 2026: $16.5B
Q4 2023: $15.4BQ1 2024: $12.7BQ2 2024: $12.8BQ3 2024: $13.3BQ4 2024: $14.3BQ1 2025: $12.7BQ2 2025: $12.9BQ3 2025: $13.7BQ4 2025: $13.7BQ1 2026: $13.6BQ2 2026: $16.1BQ3 2026: $16.5B
QuarterRevenueYoY
Q3 2026$16.5B+21%
Q2 2026$16.1B+25%
Q1 2026$13.6B+7.2%
Q4 2025$13.7B-4.1%
Q3 2025$13.7B+2.8%
Q2 2025$12.9B+0.2%
Q1 2025$12.7B-0.4%
Q4 2024$14.3B-7.4%

INTC's revenue is recovering but still below its 2021 peak: $16.5B last quarter, up 21% from the same quarter a year ago.

CREX Free Cash Flow

Q3 2023: $2MQ4 2023: −$3MQ1 2024: $2MQ2 2024: $2MQ3 2024: $543,000Q4 2024: −$1MQ1 2025: −$2MQ2 2025: $672,000Q3 2025: −$2MQ4 2025: −$7MQ1 2026: −$2MQ2 2026: $457,000
Q3 2023: $2MQ4 2023: −$3MQ1 2024: $2MQ2 2024: $2MQ3 2024: $543,000Q4 2024: −$1MQ1 2025: −$2MQ2 2025: $672,000Q3 2025: −$2MQ4 2025: −$7MQ1 2026: −$2MQ2 2026: $457,000
QuarterFree cash flowYoY
Q2 2026$457K-32%
Q1 2026-$1.9M+$551K
Q4 2025-$7M-$5.6M
Q3 2025-$1.7M-415%
Q2 2025$672K-70%
Q1 2025-$2.5M-227%
Q4 2024-$1.4M+$1.8M
Q3 2024$543K-71%

CREX's free cash flow was −$10M over the past year, against −$3M the year before.

INTC Free Cash Flow

Q4 2023: −$2.1BQ1 2024: −$7.2BQ2 2024: −$3.4BQ3 2024: −$2.4BQ4 2024: −$2.7BQ1 2025: −$4.4BQ2 2025: −$1.5BQ3 2025: $121MQ4 2025: $800MQ1 2026: −$2.5BQ2 2026: $4.5BQ3 2026: $1.1B
Q4 2023: −$2.1BQ1 2024: −$7.2BQ2 2024: −$3.4BQ3 2024: −$2.4BQ4 2024: −$2.7BQ1 2025: −$4.4BQ2 2025: −$1.5BQ3 2025: $121MQ4 2025: $800MQ1 2026: −$2.5BQ2 2026: $4.5BQ3 2026: $1.1B
QuarterFree cash flowYoY
Q3 2026$1.1B+774%
Q2 2026$4.5B+$6B
Q1 2026-$2.5B+$1.8B
Q4 2025$800M+$3.5B
Q3 2025$121M+$2.5B
Q2 2025-$1.5B+$1.9B
Q1 2025-$4.4B+$2.8B
Q4 2024-$2.7B-$597M

INTC has the edge over CREX on cash generation, producing positive trailing cash flow while its opponent burns cash.

CREX Total Shares

Q3 2023: 9MQ4 2023: 8MQ1 2024: 10MQ2 2024: 10MQ3 2024: 11MQ4 2024: 10MQ1 2025: 10MQ2 2025: 10MQ4 2025: 10MQ1 2026: 11MQ2 2026: 11M
Q3 2023: 9MQ4 2023: 8MQ1 2024: 10MQ2 2024: 10MQ3 2024: 11MQ4 2024: 10MQ1 2025: 10MQ2 2025: 10MQ4 2025: 10MQ1 2026: 11MQ2 2026: 11M
PeriodChange %Net change
Quarterly+0.2%+16K shares
1 year+1.2%+121K shares
3 years+44%+3.2M shares
5 years+211%+7.2M shares

CREX has the edge over INTC on shareholder dilution, with a more favorable share count trend.

INTC Total Shares

Q4 2023: 4.2BQ1 2024: 4.2BQ2 2024: 4.3BQ3 2024: 4.3BQ4 2024: 4.3BQ1 2025: 4.3BQ2 2025: 4.4BQ3 2025: 4.5BQ4 2025: 4.5BQ1 2026: 5.1BQ2 2026: 5.1BQ3 2026: 5.3B
Q4 2023: 4.2BQ1 2024: 4.2BQ2 2024: 4.3BQ3 2024: 4.3BQ4 2024: 4.3BQ1 2025: 4.3BQ2 2025: 4.4BQ3 2025: 4.5BQ4 2025: 4.5BQ1 2026: 5.1BQ2 2026: 5.1BQ3 2026: 5.3B
PeriodChange %Net change
Quarterly+4%+203M shares
1 year+17%+776M shares
3 years+25%+1.1B shares
5 years+30%+1.2B shares
Available history+19%+834M shares

INTC has 5.3B diluted shares, up 17% from a year ago.

CREX Net Leverage

Q3 2023: 4.8xQ4 2023: 2.3xQ1 2024: 2.1x
Q3 2023: 4.8xQ4 2023: 2.3xQ1 2024: 2.1x
QuarterNet LeverageStatus
Q1 20242.1xModerate
Q4 20232.3xModerate
Q3 20234.8xHigh
Q2 202313.2xHigh
Q1 202310.0xHigh
Q4 202245.2xHigh
Q4 20194.9xHigh

CREX's net debt is about 2.1 years of its operating earnings (EBITDA), down from 10 years a year ago.

INTC Net Leverage

Q4 2023: 4.4xQ1 2024: 4.4xQ2 2024: 4.3xQ3 2024: 23.8xQ1 2025: 69.6xQ3 2025: 4.0xQ4 2025: 3.4xQ1 2026: 3.9xQ2 2026: 3.1xQ3 2026: 2.0x
Q4 2023: 4.4xQ1 2024: 4.4xQ2 2024: 4.3xQ3 2024: 23.8xQ1 2025: 69.6xQ3 2025: 4.0xQ4 2025: 3.4xQ1 2026: 3.9xQ2 2026: 3.1xQ3 2026: 2.0x
QuarterNet LeverageStatus
Q3 20262.0xHealthy
Q2 20263.1xElevated
Q1 20263.9xElevated
Q4 20253.4xElevated
Q3 20254.0xElevated
Q1 202569.6xHigh
Q3 202423.8xHigh
Q2 20244.3xHigh

INTC's net debt is about 2.0 years of its operating earnings (EBITDA), down from 4.0 years a year ago.

CREX Weekly Momentum

MetricValueStatus
RSI33.0Neutral
Stochastic8.9Oversold

CREX's weekly RSI is 33 (neutral) and its Stochastic is 9 (oversold).

INTC Weekly Momentum

MetricValueStatus
RSI38.1Neutral
Stochastic7.7Oversold

INTC's weekly RSI is 38 (neutral) and its Stochastic is 8 (oversold).

CREX PE vs Technology Sector

MetricCREXSector medianRelative
PEN/A28x—

CREX has no meaningful PE right now: it lost money over the past year.

INTC PE vs Technology Sector

MetricINTCSector medianRelative
PEN/A28x—

INTC has no meaningful PE right now: it lost money over the past year.

CREX Weekly Moving Averages

Moving averageMA priceRelative
8 week MA$2.254.4% below
20 week MA$2.7923% below
50 week MA$3.2033% below
100 week MA$2.8725% below
200 week MA$2.9828% below

CREX is in a downtrend: it's below all five of its weekly moving averages, and 28% below its 200-week average.

INTC Weekly Moving Averages

Moving averageMA priceRelative
8 week MA$88.431% below
20 week MA$95.336% below
50 week MA$79.323% below
100 week MA$52.118% above
200 week MA$42.544% above

INTC has the edge over CREX on trend strength, trading above more of its moving averages.

CREX Yearly ROI

YearStart priceEnd priceROI
2020$4.20$3.90-7.1%
2021$3.90$4.38+12%
2022$4.38$1.71-61%
2023$1.71$2.36+38%
2024$2.36$2.69+14%
2025$2.69$2.66-1.1%
2026 YTD$2.66$2.15-19%

CREX has finished lower in three of the last six years. It's down 19% so far in 2026.

INTC Yearly ROI

YearStart priceEnd priceROI
2020$60.1$47.1-22%
2021$47.1$51.3+9%
2022$51.3$26.1-49%
2023$26.1$50.3+93%
2024$50.3$20.3-60%
2025$20.3$36.2+78%
2026 YTD$36.2$61.2+69%

INTC has the edge over CREX on returns for 2026, with the stronger performance.

Give your agent the market.

Get API key